FierceBiotech  Aug 19  Comment 
Amgen successfully wrapped its second Phase III study for AMG416, its late-stage drug for secondary hyperparathyroidism that's now one final study away from a prospective regulatory filing.
The Hindu Business Line  Aug 1  Comment 
Two years after retiring from the RBI and on dialysis now, K Pramoda Mayya is struggling to meet his medical expenses. Mayya had invested ₹35 lakh two years ago after his broker Systemat...
MedPage Today  Jul 25  Comment 
(MedPage Today) -- The novel agent ferric citrate cleared phosphate while boosting iron levels in dialysis patients, a phase III study showed.
MedPage Today  Jul 18  Comment 
(MedPage Today) -- An investigational drug for secondary hyperparathyroidism in chronic kidney disease patients on dialysis met its primary endpoint, Amgen announced.
FierceBiotech  Jul 17  Comment 
Amgen's in-development treatment for patients on kidney dialysis met its primary and secondary goals in a late-stage trial, step one in the drug's three-part Phase III program.
The Straits Times  Jul 7  Comment 
July 08, 2014 2:21 AM VETERAN investor Eddie Chng is used to hearing quirky ideas, most of which sound great in theory but are unworkable in practice.
Reuters  Jun 27  Comment 
* FMC seeks to expand services linked to core dialysis ops
NPR  Jun 20  Comment 
Medicare data show a pattern of problematic payments to doctors with a history of disciplinary action. Yet state medical boards don't usually look at billing as a trigger for investigations.
SeekingAlpha  Jun 19  Comment 
By Paulo Santos: Electromed (ELMD) is a small company selling medical devices used in airway clearance therapy. Its main product is the SmartVest system, used in high-frequency chest-wall compression (HFCWC). This technique is used to clear a...


Companies in this industry provide dialysis services to patients with diabetes. These companies make a substantial portion of their revenue from prescribing diabetes drugs. They also heavily dependent on Medicare and Medicaid.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki